Global transcriptomic analysis of breast cancer and normal mammary epithelial cells infected with Borrelia burgdorferi.
DEGs
KEGG
Lyme disease
REACTOME
TNBC
breast cancer
Journal
European journal of microbiology & immunology
ISSN: 2062-509X
Titre abrégé: Eur J Microbiol Immunol (Bp)
Pays: Hungary
ID NLM: 101569896
Informations de publication
Date de publication:
23 Nov 2023
23 Nov 2023
Historique:
received:
06
09
2023
accepted:
26
09
2023
medline:
19
10
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
epublish
Résumé
The bacterial spirochete Borrelia burgdorferi, the causative agent of Lyme Disease, can disseminate and colonize various tissues and organs, orchestrating severe clinical symptoms including arthritis, carditis, and neuroborreliosis. Previous research has demonstrated that breast cancer tissues could provide an ideal habitat for diverse populations of bacteria, including B. burgdorferi, which is associated with a poor prognosis. Recently, we demonstrated that infection with B. burgdorferi enhances the invasion and migration of triple-negative MDA-MB-231 cells which represent a type of breast tumor with more aggressive cancer traits. In this study, we hypothesized that infection by B. burgdorferi affects the expression of cancer-associated genes to effectuate breast cancer phenotypes. We applied the high-throughput technique of RNA-sequencing on B. burgdorferi-infected MDA-MB-231 breast cancer and normal-like MCF10A cells to determine the most differentially expressed genes (DEG) upon infection. Overall, 142 DEGs were identified between uninfected and infected samples in MDA-MB-231 while 95 DEGs were found in MCF10A cells. A major trend of the upregulation of C-X-C and C-C motif chemokine family members as well as genes and pathways was associated with infection, inflammation, and cancer. These genes could serve as potential biomarkers for pathogen-related tumorigenesis and cancer progression which could lead to new therapeutic opportunities.
Identifiants
pubmed: 37856211
doi: 10.1556/1886.2023.00031
pmc: PMC10668924
doi:
Types de publication
Journal Article
Langues
eng
Pagination
63-76Références
Cell Mol Life Sci. 2009 Jan;66(1):9-26
pubmed: 18726069
Front Oncol. 2019 Oct 01;9:969
pubmed: 31681561
J Am Acad Dermatol. 1991 Apr;24(4):584-90
pubmed: 2033136
Theranostics. 2017 Apr 7;7(6):1543-1588
pubmed: 28529637
Cell. 2022 Apr 14;185(8):1356-1372.e26
pubmed: 35395179
Front Microbiol. 2021 Nov 08;12:760627
pubmed: 34819924
Microbiology (Reading). 2015 Mar;161(Pt 3):516-27
pubmed: 25564498
Br J Cancer. 2006 Feb 13;94(3):346-50
pubmed: 16421592
Clin Cancer Res. 2008 Nov 1;14(21):6735-41
pubmed: 18980965
Front Med (Lausanne). 2021 Aug 18;8:666554
pubmed: 34485323
Microbes Infect. 2016 Jul-Aug;18(7-8):484-95
pubmed: 27139815
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Cancer Res. 2018 Jan 1;78(1):143-156
pubmed: 29118090
Int J Mol Sci. 2020 Jul 22;21(15):
pubmed: 32707869
Br J Cancer. 2004 Jan 26;90(2):423-9
pubmed: 14735188
J Neuroinflammation. 2008 Sep 25;5:40
pubmed: 18817547
Cell Metab. 2022 Mar 1;34(3):355-377
pubmed: 35123658
Nat Commun. 2020 Jun 26;11(1):3259
pubmed: 32591509
Microorganisms. 2023 Jun 01;11(6):
pubmed: 37374977
PLoS One. 2012;7(10):e48277
pubmed: 23110225
Infection. 1997 Jul-Aug;25(4):240-6
pubmed: 9266264
Antibiotics (Basel). 2019 Oct 11;8(4):
pubmed: 31614557
Front Microbiol. 2018 May 15;9:951
pubmed: 29867857
Front Cell Infect Microbiol. 2014 May 20;4:55
pubmed: 24904837
Cancers (Basel). 2022 Dec 28;15(1):
pubmed: 36612163
Mol Med Rep. 2020 Feb;21(2):786-794
pubmed: 31789409
Front Microbiol. 2021 Oct 12;12:711291
pubmed: 34712208
Eur J Microbiol Immunol (Bp). 2016 Feb 09;6(1):9-24
pubmed: 27141311
Int J Mol Sci. 2023 Apr 14;24(8):
pubmed: 37108425
Endocr Relat Cancer. 2007 Dec;14(4):1039-52
pubmed: 18045955
Breast Cancer Res. 2020 Jun 9;22(1):61
pubmed: 32517735
PLoS One. 2020 Jul 21;15(7):e0236187
pubmed: 32692762
Med Hypotheses. 2006;67(4):819-32
pubmed: 16828236
Cancer Sci. 2022 Apr;113(4):1140-1153
pubmed: 35102665
Molecules. 2021 Dec 27;27(1):
pubmed: 35011369
Front Immunol. 2022 Feb 25;13:813173
pubmed: 35281048
Antibiotics (Basel). 2021 Oct 24;10(11):
pubmed: 34827233
Curr Med Chem. 2015;22(2):264-89
pubmed: 25386819
Cell Death Dis. 2018 Aug 29;9(9):880
pubmed: 30158589
Curr Res Microb Sci. 2021 Oct 26;2:100078
pubmed: 34841367
Nature. 2009 Jun 18;459(7249):1005-9
pubmed: 19421193
Cold Spring Harb Protoc. 2015 Apr 13;2015(11):951-69
pubmed: 25870306
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Med Sci Monit. 2020 Jan 11;26:e918281
pubmed: 31924747
Exp Mol Pathol. 2015 Aug;99(1):163-72
pubmed: 26079660
J Clin Invest. 2017 Mar 1;127(3):780-789
pubmed: 28248200
Pathogens. 2021 Mar 02;10(3):
pubmed: 33801255
Blood. 2008 Jun 15;111(12):5524-9
pubmed: 18424667
Cancer Immunol Res. 2019 Feb;7(2):193-207
pubmed: 30514794